Misako Hirai

1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment

Misako Hirai, Sadao Yoshida, Hironobu Kashiwagi et al. · Genes Chromosomes and Cancer · 1999 · 61 citations

Glioma, Malignant Disease, Progressive Neuroblastoma Resistant +13

Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients.

Kazuya Kudoh, Manabu Takano, T Koshikawa et al. · PubMed · 1999 · 60 citations

Genetics, Gynecology, Cancer Biology +18

Inactivation of <i>p16/CDKN2</i> and <i>p15/MTS2</i> is associated with prognosis and response to chemotherapy in ovarian cancer

Kazuya Kudoh, Yoshihito Ichikawa, Sadao Yoshida et al. · International Journal of Cancer · 2002 · 48 citations

Expression of  -Fetoprotein and Prostate-specific Antigen Genes in Several Tissues and Detection of mRNAs in Normal Circulating Blood by Reverse Transcriptase-Polymerase Chain Reaction

Toru Ishikawa, Hideyuki Kashiwagi, Yusuke Iwakami et al. · Japanese Journal of Clinical Oncology · 1998 · 42 citations · Full text

Inactivation ofp16/CDKN2 andp15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors

Yoshihito Ichikawa, Sadao Yoshida, Yumi Koyama et al. · International Journal of Cancer · 1996 · 39 citations · Full text